PharmacoEconomics

Economic Evaluation and Decision Making: Reimbursing Trastuzumab in Early-Stage Breast Cancer
pp. 181-185(5)
Author: Simoens, Steven

Economic Evaluations of Cholesterol-Lowering Drugs: A Critical and Systematic Review
pp. 187-199(13)
Authors: Gumbs, Pearl D.; Verschuren, Monique W.M.; Mantel-Teeuwisse, Aukje K.; de Wit, Ardine G.; Anthonius de Boer,; Klungel, Olaf H.

Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases: The Limitations of Standard Economic Metrics as Exemplified by Fabry-Anderson Disease
pp. 201-208(8)
Authors: Moore, David F.; Ries, Markus; Forget, Evelyn L.; Schiffmann, Raphael

Do Drugs Reduce Utilisation of Other Healthcare Resources?
pp. 209-221(13)
Authors: Crémieux, Pierre-Yves; Ouellette, Pierre; Petit, Patrick

Recombinant Erythropoietin for Chemotherapy-Related Anaemia: Economic Value and Health-Related Quality-of-Life Assessment Using Direct Utility Elicitation and Discrete Choice Experiment Methods
pp. 223-237(15)
Authors: Ossa, Diego F.; Briggs, Andrew; McIntosh, Emma; Cowell, Warren; Littlewood, Tim; Sculpher, Mark

Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients
pp. 239-251(13)
Authors: Brunenberg, Danielle E.M.; Wetzels, Gwenn E.C.; Nelemans, Patricia J.; Dirksen, Carmen D.; Severens, Johan L.; Stoffers, Henri E.J.H.; Schouten, Jan S.A.G.; Prins, Martin H.; de Leeuw, Peter W.; Joore, Manuela A.

Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada
pp. 253-266(14)
Authors: Grima, Daniel T.; Thompson, Melissa F.; Sauriol, Luc